Literature DB >> 22078429

Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age.

Pyotr G Platonov1, Lubov B Mitrofanova, Victoria Orshanskaya, Siew Yen Ho.   

Abstract

OBJECTIVES: The purpose of this study was to assess the association between structural changes in human atria, age, and history of atrial fibrillation (AF).
BACKGROUND: Development of fibrosis in atrial walls is associated with deterioration of atrial conduction and predisposes to AF in experiment. Human data, however, are scarce, and whether fibrosis is a cause or consequence of AF is not known.
METHODS: Medical records for consecutive autopsies were checked for AF history and duration. Atrial specimens from 30 patients (ages 64 ± 12 years) were collected in 3 equal age-matched groups as patients without AF history, with paroxysmal AF, or with permanent AF. Tissue samples were obtained at the level of superior pulmonary veins, inferior pulmonary veins, center of posterior left atrial wall, terminal crest, and Bachmann's bundle. Histology sections were assessed for extent of fibrosis, fatty tissues, and inflammatory infiltration at each location.
RESULTS: No correlation was observed between age and fibrosis at any location. Fibrosis extent and fatty infiltration were twofold to threefold higher at all locations in patients with history of AF and correlated with lymphomononuclear infiltration. Patients with permanent AF had greater fibrosis extent than did patients with paroxysmal AF.
CONCLUSIONS: In post-mortem material, structural changes in the atria were not associated with age, but were significantly correlated with presence of AF and its severity. Our findings suggest that age-related changes per se are unlikely to be the sole cause of advanced fibrosis underlying AF. Copyright Â
© 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22078429     DOI: 10.1016/j.jacc.2011.05.061

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  119 in total

1.  Fibrosis and electrophysiological characteristics of the atrial appendage in patients with atrial fibrillation and structural heart disease.

Authors:  Thomas J van Brakel; Thomas van der Krieken; Sjoerd W Westra; Jeroen A van der Laak; Joep L Smeets; Henry A van Swieten
Journal:  J Interv Card Electrophysiol       Date:  2013-09-12       Impact factor: 1.900

2.  Right atrial diameter and outcome of catheter ablation of atrial fibrillation.

Authors:  Song -Nan Wen; Nian Liu; Rong Bai; Ri-Bo Tang; Rong-Hui Yu; De-Yong Long; Cai-Hua Sang; Chen-Xi Jiang; Song-Nan Li; Jia-Hui Wu; Yan-Fei Ruan; Rong Hu; Xin Du; Xiao-Hui Liu; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  J Interv Card Electrophysiol       Date:  2017-06-13       Impact factor: 1.900

Review 3.  Cardiac magnetic resonance for prediction of arrhythmogenic areas.

Authors:  Esra Gucuk Ipek; Saman Nazarian
Journal:  Trends Cardiovasc Med       Date:  2015-03-03       Impact factor: 6.677

4.  Human Atrial Fibrillation Drivers Resolved With Integrated Functional and Structural Imaging to Benefit Clinical Mapping.

Authors:  Brian J Hansen; Jichao Zhao; Ning Li; Alexander Zolotarev; Stanislav Zakharkin; Yufeng Wang; Josh Atwal; Anuradha Kalyanasundaram; Suhaib H Abudulwahed; Katelynn M Helfrich; Anna Bratasz; Kimerly A Powell; Bryan Whitson; Peter J Mohler; Paul M L Janssen; Orlando P Simonetti; John D Hummel; Vadim V Fedorov
Journal:  JACC Clin Electrophysiol       Date:  2018-11-01

Review 5.  Assessment and impact of cardiac fibrosis on atrial fibrillation.

Authors:  Nazem Akoum; Nassir Marrouche
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

6.  Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS).

Authors:  Michael A Rosenberg; Marlena Maziarz; Alex Y Tan; Nicole L Glazer; Susan J Zieman; Jorge R Kizer; Joachim H Ix; Luc Djousse; David S Siscovick; Susan R Heckbert; Kenneth J Mukamal
Journal:  Am Heart J       Date:  2014-02-26       Impact factor: 4.749

Review 7.  Persistent atrial fibrillation: should we always ice the back of the left atrium?

Authors:  Kavisha Patel; Jorge Romero; Luigi Di Biase
Journal:  J Interv Card Electrophysiol       Date:  2019-07-24       Impact factor: 1.900

8.  Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.

Authors:  Yoshio Takemoto; Rafael J Ramirez; Kuljeet Kaur; Oscar Salvador-Montañés; Daniela Ponce-Balbuena; Roberto Ramos-Mondragón; Steven R Ennis; Guadalupe Guerrero-Serna; Omer Berenfeld; José Jalife
Journal:  J Am Coll Cardiol       Date:  2017-12-12       Impact factor: 24.094

9.  c-Jun N-terminal kinase activation contributes to reduced connexin43 and development of atrial arrhythmias.

Authors:  Jiajie Yan; Wei Kong; Qiang Zhang; Eric C Beyer; Gregory Walcott; Vladimir G Fast; Xun Ai
Journal:  Cardiovasc Res       Date:  2012-12-14       Impact factor: 10.787

Review 10.  New approaches to managing nonvalvular atrial fibrillation: what are the thromboembolic implications?

Authors:  Peter J Kudenchuk
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.